Xanomeline Enteric is named as a drug or biological intervention in 3 clinical trials in our UK, USA, India and China trial registers, 3 of which are recruiting. The lead sponsor is Bristol-Myers Squibb. Registered phases: Phase 3 and Phase 1. Conditions studied include Healthy Volunteers; Alzheimer's Disease; Alzheimer Disease.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07011732 | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) (ClinicalTrials.gov ↗) Alzheimer Disease |
Phase 3 | Recruiting |
| NCT07011745 | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ClinicalTrials.gov ↗) Alzheimer's Disease |
Phase 3 | Recruiting |
| NCT07063342 | A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses (ClinicalTrials.gov ↗) Healthy Volunteers |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Healthy Volunteers | 1 |
| Alzheimer's Disease | 1 |
| Alzheimer Disease | 1 |
| Lead sponsor | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Register | Xanomeline Enteric trials |
|---|---|
| Clinical trials in UK | 2 |
| Clinical trials in USA | 2 |
| Clinical trials in India | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Xanomeline Enteric works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Xanomeline Enteric (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.